Patients worldwide rely on Taj Pharma’s Anti-Cancer products to meet their medical needs. Ensuring an unrestricted supply of safe medicines is of critical importance to us, and doing so requires a secure, accountable supply chain of trusted partner companies. In 2018, Taj Pharma Oncology division completed audits of 9,892 suppliers globally, and more than 11,000 supplier audits were planned for 2019.
Providing products and services to treat and monitor diseases is at the core of Taj Pharmaceutical’s activities in all major therapeutic areas. We are concentrating our efforts especially on those areas, where there are important medical needs and where patients can benefit from an adequate treatment regimen. Our product range makes it possible to offer real improvements to doctors, hospitals and patients.
Focusing on prescription drugs, we currently engage in the following areas (amongst others):
For many of these areas and the corresponding indications, Taj Pharmaceuticals has provided a large range of therapeutic options. Please view a selection of major prescription drugs by accessing the current Oncology Products overview.